SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-002917
Filing Date
2019-05-17
Accepted
2019-05-17 12:03:40
Documents
2
Period of Report
2019-05-17
Items
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bkit_8k.htm 8-K 14847
2 LETTER OF RESIGNATION bkit_ex17.htm EX-17 2141
  Complete submission text file 0001477932-19-002917.txt   18349
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55022 | Film No.: 19834804
SIC: 7200 Services-Personal Services